Cuprina Holdings (Cayman) Limited Class A ( (CUPR) ) has provided an announcement.
On April 6, 2025, Cuprina Holdings completed the construction of an in-vitro fertilization (IVF) media production facility in Singapore, in collaboration with Ferti-Craft Pte Ltd. The facility has received ISO 13485 certification and a dealer license, enabling it to produce 14 SKUs of IVF media products. This strategic move positions Cuprina to expand its market presence in Singapore and potentially in ASEAN countries, the Middle East, and other global markets, aligning with the growing assisted reproductive technology market.
More about Cuprina Holdings (Cayman) Limited Class A
Cuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company focused on developing and commercializing products for chronic wound management and infertility, as well as cosmeceuticals in the health and beauty sector.
YTD Price Performance: 46.51%
Average Trading Volume: 389,575
For a thorough assessment of CUPR stock, go to TipRanks’ Stock Analysis page.